Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging Biomarkers to Predict Responsiveness to Tumor Treating Fields in Patients With High Grade Glioma

NCT03642080 is registered in ClinicalTrials.gov with New York Presbyterian Brooklyn Methodist Hospital as lead sponsor.

NCT NCT03642080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging Biomarkers to Predict Responsiveness to Tumor Treating Fields in Patients With High Grade Glioma
Lead sponsor
New York Presbyterian Brooklyn Methodist Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2018
Completion date
December 31, 2023
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme